Cargando…
Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a progressive and devastating disease characterized by pulmonary artery vasoconstriction and vascular remodeling leading to vascular rarefaction with elevation of pulmonary arterial pressures and pulmonary vascular resistance. Often PAH will cause death from...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380049/ https://www.ncbi.nlm.nih.gov/pubmed/34429666 http://dx.doi.org/10.2147/JEP.S236743 |